 We have demonstrated that a cyclic dipeptide Cyclo his-pro plus zinc Cyclo-Z treatment improved clinical conditions of diabetes in various animal models and a phase 1 clinical trial. The main objective of this study is to demonstrate that this product is safe and effective for the treatment of human diabetes. 